|
May 2
|
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
|
|
May 2
|
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
|
|
May 2
|
Q1 2024 Summit Therapeutics Inc Earnings Call
|
|
May 1
|
Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2024
|
|
Apr 24
|
Summit Therapeutics to Host First Quarter 2024 Financial Results & Operational Progress Call on May 1, 2024
|
|
Apr 11
|
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
|
|
Apr 10
|
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
|
|
Apr 2
|
Insiders Are Buying These 11 Penny Stocks
|
|
Mar 29
|
Why Summit Therapeutics Stock Crushed the Market This Week
|
|
Mar 25
|
Summit Therapeutics Insiders Up US$5.1m On US$5.05m Investment
|
|
Mar 22
|
Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024
|
|
Mar 14
|
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024
|
|
Mar 5
|
Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
|
|
Nov 8
|
Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Summit Therapeutics Inc (SMMT) Reports Q3 Financial Results and Operational Progress
|
|
Nov 7
|
Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2023
|
|
Aug 10
|
Q2 2023 Summit Therapeutics Inc Earnings Call
|
|
Aug 9
|
Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2023
|